Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. S. Tjulandina
Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting
Malignant tumours
Criteria for Selection of Patients With High Chance of Complete or Optimal Debulking in Advanced Ovarian Cancer
Malignant tumours
Related publications
Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy
Cancer Management and Research
Oncology
Treatment of Nausea and Vomiting During Chemotherapy
Oncology & Hematology Review (US)
Olanzapine Combined With Standard Antiemetic Regimens for Prevention of Chemotherapy Therapy-Induced Nausea and Vomiting: A Single-Center Experience From South India
Asian Journal of Pharmaceutical and Clinical Research
Pharmacology
Pharmaceutical Science
Dronabinol for Chemotherapy-Induced Nausea and Vomiting Unresponsive to Antiemetics
Cancer Management and Research
Oncology
Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic
BMJ
Rolapitant in the Treatment of Nausea and Vomiting Associated With Chemotherapy
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Stability of Azasetron-Dexamethasone Mixture for Chemotherapy-Induced Nausea and Vomiting Administration
Oncotarget
Oncology
Neurokinin-1 Receptor Antagonists: Review of Their Role for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
